Cargando…

CDH13 promoter methylation regulates cisplatin resistance of non-small cell lung cancer cells

Reversing cisplatin resistance of lung cancer cell line A549/DDP through recovering cadherin 13 (CDH13) expression by demethylation was investigated in the current study. RT-PCR was used to measure CDH13 expression in lung cancer A549 and A549/DDP cells with or without 5-Aza-CdR intervention. Methyl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yan, Zhang, Lei, Yang, Jiasheng, Li, Bin, Wang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176259/ https://www.ncbi.nlm.nih.gov/pubmed/30344726 http://dx.doi.org/10.3892/ol.2018.9325

Ejemplares similares

Aberrant methylation of CDH13 can be a diagnostic biomarker for lung adenocarcinoma
por: Pu, Weilin, et al.
Publicado: (2016)

CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer
por: Hibi, K, et al.
Publicado: (2004)

Clinical Relevance of CDH1 and CDH13 DNA-Methylation in Serum of Cervical Cancer Patients
por: Abudukadeer, Abida, et al.
Publicado: (2012)

CDH13 promoter SNPs with pleiotropic effect on cardiometabolic parameters represent methylation QTLs
por: Putku, Margus, et al.
Publicado: (2014)

miR-25 promotes invasion of human non-small cell lung cancer via CDH1
por: Liu, Bing, et al.
Publicado: (2019)

Methylation pattern of CDH13 gene in digestive tract cancers
por: Hibi, K, et al.
Publicado: (2004)

Hypoxic non-small-cell lung cancer cell-derived exosomal miR-21 promotes resistance of normoxic cell to cisplatin
por: Dong, Caijun, et al.
Publicado: (2019)

Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis
por: Chen, Feng, et al.
Publicado: (2016)

MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
por: Fadejeva, Irina, et al.
Publicado: (2017)

A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis
por: Yang, Jingyu, et al.
Publicado: (2016)

EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations
por: Gao, Jing, et al.
Publicado: (2016)

Genetic variation in CDH13 gene was associated with non-small cell lung cancer (NSCLC): A population-based case-control study
por: Li, Yingfu, et al.
Publicado: (2017)

SKA1 regulates the metastasis and cisplatin resistance of non-small cell lung cancer
por: SHEN, LIHUA, et al.
Publicado: (2016)

Inhibitors of Jumonji C domain-containing histone lysine demethylases overcome cisplatin and paclitaxel resistance in non-small cell lung cancer through APC/Cdh1-dependent degradation of CtIP and PAF15
por: Duan, Lei, et al.
Publicado: (2022)

FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
por: He, Lingfeng, et al.
Publicado: (2017)

FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
por: He, Lingfeng, et al.
Publicado: (2017)

Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer
por: Xiao, Lu, et al.
Publicado: (2017)

Long non‐coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation‐dependent repression of CDH1 promoter
por: Gao, Li‐Ming, et al.
Publicado: (2019)

Methylation pattern of CDH1 promoter and its association with CDH1 gene expression in cytological cervical specimens
por: Holubeková, Veronika, et al.
Publicado: (2016)

Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer
por: Guo, Qiang, et al.
Publicado: (2016)

Gambogenic acid exerts anticancer effects in cisplatin-resistant non-small cell lung cancer cells
por: Shen, Daofu, et al.
Publicado: (2020)

Acquired differential regulation of caspase-8 in cisplatin-resistant non-small-cell lung cancer
por: Paul, I, et al.
Publicado: (2012)

Elevated HMGB1 promotes the malignant progression and contributes to cisplatin resistance of non-small cell lung cancer
por: Ma, Ying, et al.
Publicado: (2023)

Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
por: Stathopoulos, G. P., et al.
Publicado: (2011)

Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cells
por: Li, Amin, et al.
Publicado: (2020)

MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
por: Li, Weili, et al.
Publicado: (2016)

The methylation profiles of PRDM promoters in non–small cell lung cancer
por: Tan, Shuang-xiang, et al.
Publicado: (2018)

Hypoxia-induced Tie1 drives stemness and cisplatin resistance in non-small cell lung carcinoma cells
por: Li, Chaojie, et al.
Publicado: (2021)

LINC02389/miR-7-5p Regulated Cisplatin Resistance of Non-Small-Cell Lung Cancer via Promoting Oxidative Stress
por: Ma, Peng, et al.
Publicado: (2022)

Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells
por: Zhou, Huiling, et al.
Publicado: (2023)

Up-regulation of fas reverses cisplatin resistance of human small cell lung cancer cells
por: Wu, Wei, et al.
Publicado: (2010)

Downregulation of CDH11 Promotes Metastasis and Resistance to Paclitaxel in Gastric Cancer Cells
por: Yang, Zhongyin, et al.
Publicado: (2021)

Interactive association between dietary fat and sex on CDH13 cg02263260 methylation
por: Shiu, Bei-Hao, et al.
Publicado: (2021)

Predictable Resistance and Overall Survival of Gemcitabine/Cisplatin by Platelet Activation Index in Non-Small Cell Lung Cancer
por: Shi, Liang, et al.
Publicado: (2018)

The Noncoding RNA Expression Profile and the Effect of lncRNA AK126698 on Cisplatin Resistance in Non-Small-Cell Lung Cancer Cell
por: Yang, Yong, et al.
Publicado: (2013)

Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G(2)/M cell cycle arrest
por: Sarin, Navin, et al.
Publicado: (2017)

hTERT promoter methylation promotes small cell lung cancer progression and radiotherapy resistance
por: Zhai, Guangsheng, et al.
Publicado: (2020)

Aberrant Methylation of CDH13 is a Potential Biomarker for Predicting the Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer
por: Lin, Ying-Li, et al.
Publicado: (2014)

LncRNA KCNQ1OT1 promotes cell proliferation, migration and invasion via regulating miR-129-5p/JAG1 axis in non-small cell lung cancer
por: Wang, Yan, et al.
Publicado: (2020)

YAP promotes erlotinib resistance in human non-small cell lung cancer cells
por: Hsu, Ping-Chih, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8pqrvb4105guikvoert38p3af2